Danaher Corporation $DHR is Wormser Freres Gestion’s 9th Largest Position

Wormser Freres Gestion lifted its holdings in shares of Danaher Corporation (NYSE:DHR) by 586.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 37,860 shares of the conglomerate’s stock after purchasing an additional 32,347 shares during the quarter. Danaher accounts for approximately 4.9% of Wormser Freres Gestion’s portfolio, making the stock its 9th largest position. Wormser Freres Gestion’s holdings in Danaher were worth $8,670,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. JPL Wealth Management LLC purchased a new position in shares of Danaher during the third quarter worth about $25,000. Elevated Capital Advisors LLC purchased a new position in shares of Danaher during the fourth quarter worth about $26,000. WFA of San Diego LLC purchased a new position in shares of Danaher during the second quarter worth about $26,000. ANTIPODES PARTNERS Ltd purchased a new position in shares of Danaher during the third quarter worth about $27,000. Finally, Financial Life Planners purchased a new position in shares of Danaher during the third quarter worth about $32,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

Shares of Danaher stock opened at $182.73 on Friday. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. The company has a market cap of $129.33 billion, a PE ratio of 35.34, a P/E/G ratio of 2.44 and a beta of 0.81. The business has a 50 day moving average of $182.11 and a 200 day moving average of $207.48. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80.

Danaher (NYSE:DHR) last announced its earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. The company had revenue of $5.95 billion during the quarter, compared to the consensus estimate of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The firm’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.88 earnings per share. As a group, equities research analysts forecast that Danaher Corporation will post 8.43 earnings per share for the current year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a $0.40 dividend. The ex-dividend date is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. Danaher’s dividend payout ratio is 30.95%.

Wall Street Analyst Weigh In

Several brokerages have recently commented on DHR. The Goldman Sachs Group cut their price objective on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a report on Monday, April 13th. Robert W. Baird cut their target price on Danaher from $251.00 to $249.00 and set an “outperform” rating for the company in a research note on Friday, April 17th. Guggenheim reduced their price target on shares of Danaher from $275.00 to $235.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. Wall Street Zen cut shares of Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, April 25th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Danaher in a research report on Friday, March 27th. Twenty equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $238.24.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.